Unknown

Dataset Information

0

Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study.

ABSTRACT: Background:Helicobacter pylori infection has been associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD). This study was done to evaluate the effect of H. pylori-eradication therapy (HPET) in patients with NAFLD compared to standard management therapy (SMT). Methods:Eighty NAFLD patients with H. pylori co-infection were randomized into SMT (diet and exercise, n?=?36) and HPET (SMT plus amoxicillin, clarithromycin, and pantoprazole, n?=?44) groups. The controlled attenuation parameter (CAP), anthropometric parameters, liver enzymes, lipid profile, and glycemic parameters including homeostasis model assessment-insulin resistance (HOMA-IR) were measured and compared between two groups at the baseline and 24?weeks. Results:Sixty-four participants (SMT group [n?=?28] and HPET group [n?=?36]) were included in a modified intention-to-treat analysis. Both the SMT group and the HPET group had a significant reduction in CAP scores at 24?weeks (P?=?0.002 and P?

SUBMITTER: Maharshi V 

PROVIDER: S-EPMC7261206 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Effect of <i>Helicobacter pylori</i>-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study.

Maharshi Vikas V   Gupta Pooja P   Kumar Vijay L VL   Upadhyay Ashish Datt AD   Das Prasenjit P   Yadav Rajni R   Nayak Baibaswata B   Kumar Ramesh R   Shalimar  

Gastroenterology report 20191125 2

<h4>Background</h4><i>Helicobacter pylori</i> infection has been associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD). This study was done to evaluate the effect of <i>H. pylori</i>-eradication therapy (HPET) in patients with NAFLD compared to standard management therapy (SMT).<h4>Methods</h4>Eighty NAFLD patients with <i>H. pylori</i> co-infection were randomized into SMT (diet and exercise, <i>n </i>=<i> </i>36) and HPET (SMT plus amoxicillin, clarithromycin, and pa  ...[more]

Similar Datasets

Unknown The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial.
| S-EPMC3867002 | biostudies-literature
Unknown Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD).
| S-EPMC7146245 | biostudies-literature
Unknown Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density.
| S-EPMC8964007 | biostudies-literature
Unknown Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China.
| S-EPMC8867781 | biostudies-literature
Unknown Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease.
| S-EPMC7260323 | biostudies-literature
Unknown Alcohol-Induced Hepatic Steatosis: A Comparative Study to Identify Possible Indicator(s) of Alcoholic Fatty Liver Disease.
| S-EPMC6483099 | biostudies-literature
Unknown Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model.
| S-EPMC6539878 | biostudies-literature
Unknown Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients.
| S-EPMC9013609 | biostudies-literature
Unknown Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease.
| S-EPMC8387962 | biostudies-literature
Unknown Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy.
| S-EPMC8272374 | biostudies-literature